Electronic Dashboard to Improve Outcomes in Pediatric Patients With Type 1 Diabetes Mellitus

Lily Sandblom1, Chirag Kapadia2, Vinay Vaidya2

  • 1University of Arizona College of Medicine-Phoenix, Phoenix, AZ, USA.

Insights

An electronic dashboard improved outcomes for pediatric patients with type 1 diabetes mellitus (T1DM). This tool enhanced patient education, appointment compliance, and follow-up care, leading to better glycemic control and fewer hospital admissions.

Area of Science:

  • Pediatric Endocrinology
  • Digital Health Interventions
  • Chronic Disease Management

Background:

  • Increasing incidence of type 1 diabetes mellitus (T1DM) in children.
  • Challenges in achieving optimal glycemic control in pediatric T1DM.
  • Potential of electronic health data for improving patient outcomes.

Purpose of the Study:

  • To evaluate the impact of an electronic dashboard on pediatric T1DM patient outcomes.
  • To assess if data-driven population-based interventions improve diabetes management.
  • To test the hypothesis that electronic dashboard monitoring enhances T1DM care.

Main Methods:

  • Retrospective analysis of pediatric T1DM patients at Phoenix Children's Hospital.
  • Utilized an electronic dashboard to collect patient data.
  • Analyzed diabetes management activities and patient outcomes including A1C, admissions, and follow-up care.

Main Results:

  • Increased patient education from 48% to 80%.
  • Improved appointment compliance and timely post-hospitalization follow-up.
  • Median A1C levels decreased from 9.1% to 8.2%; hospital admissions and ED visits reduced by 20%.

Conclusions:

  • Implementation of an electronic dashboard significantly improved outcomes for pediatric T1DM patients.
  • The electronic dashboard serves as a valuable tool for enhancing care in T1DM and other chronic pediatric conditions.
  • This data-driven approach can be adopted by other institutions to improve pediatric chronic disease management.
Abstract

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
322
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
617
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
220
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.1K